Masonic Cancer Center, University of Minnesota

What's Inside

Quick Links for:

Cancer Information Line
Ask about cancer, clinical trials, and how to make an appointment:
ccinfo@umn.edu
612-624-2620

Toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN
(1-888-226-2376)

A Comprehensive Cancer Center Designated by the National Cancer Institute
Print this page. Mail this link to a friend.

August 2007
Funding News and Opportunities

The following funding news and opportunities were collected recently by Cancer Center Pre-Award Services and published in Cancer Center Update, a weekly e-newsletter for members and staff.

Visit the Research Funding Resources page for links to resources you can use to search for funding as well as University resources essential to application processes.

August 28, 2007

Request for breast cancer detection pilot project applications
Friends for an Earlier Breast Cancer Test
Deadline: December 1, 2007

Applications are requested for pilot projects that focus on new methods to improve detection of early breast cancer with special interest in the development of new techniques in the areas of biological or immunologic methods of early detection. It is hoped that the pilot projects will provide preliminary data that leads to applications for more substantial peer-reviewed funding.

Applications are accepted form both established investigators who have funding but want to embark on a new area, as well as those less experienced.

Proposals should represent a new approach to the area of interest. Funds will not be given to enhance an ongoing area of research unless it is clear that a new line of inquiry is being explored. International proposals are welcome. Visit the Web site to learn how to apply.

August 21, 2007

Morris Animal Foundation Request for Research Proposals (RFP) in Canine Cancer Prevention (PDF)
Application Receipt Date: January 1, 2008
Funding: $500,000-$1,000,000/five years

The proposed studies should be multi-disciplinary and multi-institutional in nature and utilize the collective expertise of basic scientists, epidemiologists, and clinicians. The principal investigator should be an established researcher with a proven track record of productivity in laboratory or population-based veterinary cancer research, or other relevant research that positions a team to develop novel approaches for cancer prevention. Research proposals should be hypothesis-driven or exploratory in nature with convincing promise for identifying new genetic and environmental risk factors or utilizing recently identified risk factors to contribute to a better understanding of biological mechanisms for cancer development, progression, or treatment. Identification of novel methods for the early detection of cancer is encouraged. Application guidelines and more information is available at the Morris Foundation Web site (PDF).

August 14, 2007

Genome-wide Association Studies in the Genes, Environment, and Health Initiative - Study Investigators (U01)
(RFA-HG-07-012)
National Cancer Institute
Application Receipt Date(s): October 18, 2007
Funding: $750,000 in direct costs for project period July 1, 2008 to June 30, 2010

The purpose of this funding opportunity is to provide support for investigative groups to conduct genome-wide association (GWA) genotyping and/or replication studies, using data and specimens from human subjects on whom information is available for conditions/traits of public health importance and relevant environmental exposures. It includes support for sharing the specimens and data and analyzing the resulting data as part of the NIH-wide Genes, Environment, and Health Initiative (GEI).

Epidemiologic Investigation of Putative Causal Genetic Variants—Study Investigators (U01)
(RFA-HG-07-014)
National Cancer Institute
Application Receipt Date(s): November 19, 2007
Funding: up to 4 years, direct costs up to $1.1 million in FY08 and FY09, $1.2 million in FY10 and FY11.
The purpose of this funding opportunity is to provide support for the investigation, in well-characterized population studies, of genetic variants identified as potentially causally associated with complex diseases in genome-wide association (GWA) and other genetic studies, with the aim of widespread sharing of the resulting population-based descriptive and association data to accelerate the understanding of genes related to complex diseases.

August 7, 2007

Travel grant opportunity for ASCO members
Academic oncologists at the assistant to associate professor level who are working in translational research are invited to apply for a grant to attend the European Organization for Research and Treatment of Cancer (EORTC)-National Cancer Institute (NCI)-American Society of Clinical Oncology (ASCO ) Diagnostic Development Tutorial, "From Hypothesis to Product." This Tutorial is being held in Brussels, Belgium, November 14-15, 2007 in conjunction with the EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer." The Tutorial is designed to address critical issues that must be considered when developing tools to aid clinical decision-making for patients with cancer. In addition to industry participants, there will be 20 young (under age 40) academic oncologists invited to participate, five of whom will be identified by ASCO and the NCI.

Those applying to be one of the five selected by ASCO and the NCI, should submit:

  • CV
  • ASCO membership number (grant recipient must be an ASCO member)
  • Statement of Interest (up to 2 pages) which includes:
    • A description of previous research background.
    • How their experience makes them an ideal candidate for the Tutorial.
    • How the Tutorial's objectives meet or will assist in meeting research objectives.
  • A letter from the division director endorsing their current research plan and attendance at the meeting.

The grant will include registration, travel and hotel for the Tutorial and the conference.

To apply for this grant, the requested materials should be sent via e-mail attachment to ENASCOgrant@asco.org by 5 p.m. EST on August 31, 2007.